Directors



Victoria J. Fraser, MD, is the J. William Campbell Professor of Medicine, head of the Department of Medicine and and co-director of the Division of Infectious Diseases at Washington University School of Medicine in St. Louis.
Her research focuses on the prevention and control of hospital-acquired infections. She has studied surgical site infections, blood stream infections and ventilator-associated pneumonia, and her team looks at risk factors, outcomes and costs of these infections as well as how to prevent them. This research and the work of the BJC HealthCare Infection Control Consortium have led to dramatic declines in the rates of hospital-associated infections at BJC facilities over the past decade.
Fraser is co-principal investigator of the Washington University Institute of Clinical and Translational Sciences and is principal investigator of the research, education, training and clinical development arm. She also serves as physician-in-chief at Barnes-Jewish Hospital.
Fraser earned a medical degree from the University of Missouri-Columbia and completed a residency at the University of Colorado Health Sciences Center, where she also was chief resident.

 



Anthony D. Harris, MD, MPH is an infectious disease physician and epidemiologist whose research interests include emerging pathogens, antimicrobial-resistant bacteria, hospital epidemiology/infection control, epidemiologic methods in infectious diseases and medical informatics. He has published over 160 papers. He has current or has had funding from the NIH, CDC and AHRQ to study antibiotic resistance and hospital epidemiology.

 



Leonard A. Mermel, DO, FACP, FIDSA, FSHEA is Professor of Medicine, Warren Alpert Medical School of Brown University, Medical Director, Epidemiology & Infection Control Dept., Rhode Island Hospital (RIH). He was Technical Expert Panel Member, Medicare Patient Safety Monitoring System, 2005 President, Society for Healthcare Epidemiology of America (SHEA), 2014 recipient of the SHEA Mentor Scholar Award, 2016 Milton W. Hamolsky Outstanding Physician Award by the RIH Medical Staff Assn. He received the Ralph A. Kinsella, Sr. Memorial Tribute Award, St. Louis University, SHEA Young Investigator Award, Brown Medical School Department of Medicine Chairman’s Award for Outstanding Teaching. He is a member, Delta Omega Honorary Public Health Society. He is listed in Best Doctors in America, America’s Top Doctors, Guide to America’s Top Physicians, The Leading Physicians of the World, Best of Rhode Island – Infectious Diseases Physician, Castle Connolly Top Doctor, Consumer’s Checkbook’s Top Doctors, Guide to America’s Top Physicians, Who’s Who in America, Who’s Who in Science & Engineering. He has co-authored over 250 articles, text chapters and abstracts on infection control & infectious diseases. He lectures & teaches internationally. His research interest is prevention of healthcare-associated infections.

 



David A Pegues, MD is Professor of Medicine at The Hospital of The University of Pennsylvania. He received his MD from the University Of Chicago Pritzker School Of Medicine in 1986. His clinical expertise is in Transplant infectious diseases, healthcare-associated infections including catheter-associated urinary tract infections and Salmonellosis. Dr. Pegues’ current research interests include evaluating clinical decision support tools to improve the use of medical devices, microbiology testing and antimicrobial therapy for infection diagnosis and management; evaluating novel technologies and implementation strategies to reduce environmental microbial contamination and infection risk; and the epidemiology and prevention of infections in solid organ transplant recipients.

 
 
 


Dr. Thom received her M.D. from the University of Florida College of Medicine. She then completed her internal medicine residency and infectious disease fellowship at the University of Maryland Medical Center and the Baltimore VA Medical Center. She received her M.S. in Epidemiology and Clinical Research from the Department of Epidemiology and Public Health at the University of Maryland School of Medicine.
Dr. Thom is an infectious disease physician and clinical investigator. She is an Associate Professor in the Departments of Epidemiology and Public Health and Medicine. Dr. Thom was recently appointed as Assistant Dean for Student Research and Education and directs the Office of Student Research. She is also an Associate Hospital Epidemiologist for the University of Maryland Medical Center and an Physician Advisor for Quality at the University of Maryland Medical System.

 
 



Trish M. Perl, MD, MSC is Chief of Infectious Diseases and Jay P Sanford Professor of Medicine at University of Texas Southwestern. Dr. Perl is specialist in health care-associated infections, antimicrobial-resistant organisms, emerging pathogens, and infection prevention.
She earned her medical degree at the University of North Carolina School of Medicine, did her residency at Royal Victoria Hospital at McGill University in Montreal, and did her fellowship in clinical epidemiology and infectious diseases at the University of Iowa. Dr. Perl also did a two-year stint with the Canadian equivalent of the Epidemic Intelligence Service, and her first outbreak investigation – an encephalopathy caused by eating mussels – was published in the New England Journal of Medicine. Her research interests include antimicrobial resistance, C. difficile, healthcare associated infections, infection prevention and control, resistant gram negative infections, S. aureus infections, surgical site infections.

 


Aaron M. Milstone, MD, MHS, is an Associate Professor of Pediatrics and Epidemiology at The Johns Hopkins University. He is an Infectious Diseases consultant and an Associate Hospital Epidemiologist at The Johns Hopkins Hospital and serves on multiple national committees and writing groups guiding practices to prevent healthcare associated infections (HAIs) and emergence of antibiotic resistance. Dr. Milstone is an NIH, CDC and AHRQ-funded investigator. His research studies are helping to define the prevalence and transmission of multidrug-resistant bacteria, identify interventions to reduce their spread and prevent HAIs, and to understand the epidemiology and prevention of bloodstream infections.